Which has the lower trailing P/E, BSX or HCA?

HCA has the lower trailing P/E: BSX trades at 18.31 and HCA at 14.24. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BSX or HCA?

Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus HCA at 6.85%.

Does BSX or HCA pay a bigger dividend?

HCA pays a dividend (0.70% yield), while BSX has no payments in the available dividend history.

Is BSX or HCA more profitable?

BSX runs the higher net margin — BSX at 17.47% versus HCA at 8.77%.

How have BSX and HCA total returns compared?

Over the past 10 years, BSX delivered 6.22% and HCA delivered 19.72% annualized total return. Past performance doesn't predict future results.

Boston Scientific Corporation (BSX) vs HCA Healthcare, Inc. (HCA)

A side-by-side comparison of Boston Scientific Corporation and HCA Healthcare, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

BSX

Boston Scientific Corporation

$66.96B

$45.05HealthcareDelayed quote: Sep 14, 2026, 4:00 PM EDT

HCA

HCA Healthcare, Inc.

$92.12B

$425.49HealthcareDelayed quote: Sep 14, 2026, 4:00 PM EDT

Total return — BSX vs HCA

growth of $100 · dividends reinvested · last 10y

BSX +76.1% (+5.8%/yr)HCA +512.0% (+19.9%/yr)HCA compounded faster over this window

BSX HCA

BSX vs HCA: by the numbers

•HCA is the larger company ($92.12B vs $66.96B market cap).
•HCA trades at the lower trailing earnings multiple (14.24 vs 18.31 P/E), one valuation lens rather than an overall verdict.
•BSX converts more revenue to profit (17.47% vs 8.77% net margin).
•BSX grew revenue faster over the past five years (13.40% vs 6.85% CAGR).
•HCA pays a dividend (0.70% yield), while BSX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	BSX	HCA
P/E ratio	18.31	14.24
Forward P/E	13.70	14.44
P/S ratio	3.19	1.18
P/B ratio	2.69	N/A
EV / EBITDA	13.64	8.88
FCF yield	5.41%	6.51%

Profitability

Metric	BSX	HCA
Gross margin	71.16%	41.50%
Operating margin	21.46%	15.48%
Net margin	17.47%	8.77%
ROE	14.71%	N/A
ROIC	10.57%	19.41%

Dividends

Metric	BSX	HCA
Dividend yield	N/A	0.70%
Payout ratio	N/A	10.04%

Growth (annualized)

Metric	BSX	HCA
Revenue CAGR (5Y)	13.40%	6.85%
EPS CAGR (5Y)	N/A	20.90%
FCF CAGR (5Y)	15.64%	56.45%
Total return CAGR (5Y)	-0.67%	11.63%

Frequently asked

Which has the lower trailing P/E, BSX or HCA?: HCA has the lower trailing P/E: BSX trades at 18.31 and HCA at 14.24. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BSX or HCA?: Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus HCA at 6.85%.
Does BSX or HCA pay a bigger dividend?: HCA pays a dividend (0.70% yield), while BSX has no payments in the available dividend history.
Is BSX or HCA more profitable?: BSX runs the higher net margin — BSX at 17.47% versus HCA at 8.77%.
How have BSX and HCA total returns compared?: Over the past 10 years, BSX delivered 6.22% and HCA delivered 19.72% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BSX analysis Full HCA analysis Interactive comparison tool

Dig into the metrics

Boston Scientific P/E ratio HCA Healthcare P/E ratio HCA Healthcare dividend yield Boston Scientific ROE HCA Healthcare ROE Boston Scientific operating margin HCA Healthcare operating margin Boston Scientific revenue growth HCA Healthcare revenue growth Boston Scientific free cash flow HCA Healthcare free cash flow

Boston Scientific & HCA Healthcare appear in these rankings

Highest ROIC Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.